S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Actualizaciones en tiempo real para Biotron Ltd [BIT.AX]

Bolsa: ASX Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización26 abr 2024 @ 02:10

-10.29% $ 0.0610

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 02:10):
Profile picture for Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia...

Stats
Volumen de hoy 6.84M
Volumen promedio 2.35M
Capitalización de mercado 61.35M
EPS $0 ( 2024-02-27 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.10
ATR14 $0.00100 (1.64%)

Biotron Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biotron Ltd Finanzas

Annual 2023
Ingresos: $1.43M
Beneficio Bruto: $1.39M (96.97 %)
EPS: $-0.00430
FY 2023
Ingresos: $1.43M
Beneficio Bruto: $1.39M (96.97 %)
EPS: $-0.00430
FY 2023
Ingresos: $0
Beneficio Bruto: $0 (0.00 %)
EPS: $0
FY 2022
Ingresos: $1.56M
Beneficio Bruto: $1.51M (97.10 %)
EPS: $-0.00380

Financial Reports:

No articles found.

Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico